This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BIOMEMS

REGULATION OVERVIEW

The regulation particulars for medical device development, included organisms and process overview, are described for five different regions: Europe, North America, Japan, China and India. This section is particularly important for microsystem device and systems manufacturers. A COMPLETE DESCRIPTION OF DIFFERENT HEALTHCARE MARKETS AND APPLICATIONS

Microsystem devices have applications in four key healthcare markets: pharmaceutical, in-vitro diagnostics, medical devices and medical home care. Each of these markets has its own unique dynamics, players and global drivers. Motivation for the acceptance of BioMEMS technologies is highly dependent on each individual market. Whereas the acceptance of microsystems is linked to sensibility and automation constraints in the pharmaceutical market, in the in-vitro diagnostic market it's all about portability and cost reduction; while the medical devices market is focused on addition of functionalities. Concerning the home care market, the motivations are to increase system safety and connectivity. The report reviews all four of these markets in a detailed manner.

Yole Développement's experts have identified a number of applications for each device type. These applications can be placed into five groups: patient monitoring, patient care, medical imaging, in-vitro diagnostic testing and drug delivery. For each of these groups, the report provides an overview of devices and key market drivers, along with market data.

The BioMEMS 2013 report also pays particular attention to Chinese microsystems players, as a number of new players have recently entered the market.

OBJECTIVES OF THE REPORT

The report objectives are as follows:

• Provide a robust analysis of the micro devices used to develop innovative solutions for healthcare applications.• Compare Yole Développement's previous forecast with current market data and draw conclusions.• Deliver the following information for each device category: market insights, main device manufacturers and system integrators, and main trends.• Describe the market drivers per application group.

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,119.69 -43.30 -0.24%
S&P 500 2,119.06 -4.42 -0.21%
NASDAQ 5,094.12 -12.4730 -0.24%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs